EU Legislation Pharmacovigilance for Authorized Products - In July 2012, a series of pharmaceutical legislation became effective in the European Union, which included new requirements for Marketing Authorization Holders (MAH), as detailed within this document.
PRA Health Sciences
Interested in Participating in our User Research?
PRA Health Sciences is conducting a user research study to determine the effects of our decentralized services and their impact on existing markets. Your participation in this initial screening will help shape our future goals and objectives moving forward, simply click on the link below to get started.
Any information provided to PRA Health Sciences during the course of this screening will be used for the purposes of this study, and will not be shared or sold to any third parties.